Article
Basic FGF or VEGF gene therapy corrects insufficiency in the intrinsic healing capacity of tendons
11 Feb 2016
Abstract excerpt
Tendon injury during limb motion is common. Damaged tendons heal poorly and frequently undergo unpredictable ruptures or impaired motion due to insufficient innate healing capacity. By basic fibroblast growth factor (bFGF) or vascular endothelial growth factor (VEGF) gene therapy via adeno-associated viral type-2 (AAV2) vector to produce supernormal amount of bFGF or VEGF intrinsically in the tendon, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
